2022 Q3 Form 10-Q Financial Statement

#000149315222033104 Filed on November 21, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $0.00 $50.00K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit $50.00K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $2.355K $107.1K
YoY Change -97.8% 58.76%
% of Gross Profit 214.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.298K $1.300K
YoY Change -0.15% 71.05%
% of Gross Profit 2.6%
Operating Expenses $339.0K $108.4K
YoY Change 212.86% 58.89%
Operating Profit -$339.0K -$58.36K
YoY Change 480.91% -14.43%
Interest Expense $279.6K -$133.8K
YoY Change -308.94% -59.74%
% of Operating Profit
Other Income/Expense, Net $279.6K $178.0K
YoY Change 57.05%
Pretax Income -$59.46K $119.6K
YoY Change -149.7% -123.2%
Income Tax
% Of Pretax Income
Net Earnings -$59.46K $119.6K
YoY Change -149.7% -123.2%
Net Earnings / Revenue 239.28%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$4.16 $8.23
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 14.28B shares

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.650K $66.33K
YoY Change -94.5% 393.53%
Cash & Equivalents $3.648K $66.33K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $5.000K $15.00K
Other Receivables $17.38K $28.03K
Total Short-Term Assets $37.96K $109.4K
YoY Change -65.29% -13.57%
LONG-TERM ASSETS
Property, Plant & Equipment $21.65K $26.84K
YoY Change -19.35% -17.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $371.6K
YoY Change
Total Long-Term Assets $371.6K $500.2K
YoY Change -25.69% -69.3%
TOTAL ASSETS
Total Short-Term Assets $37.96K $109.4K
Total Long-Term Assets $371.6K $500.2K
Total Assets $409.6K $609.5K
YoY Change -32.8% -65.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.44K $4.260K
YoY Change 637.98% -99.17%
Accrued Expenses $51.95K $29.33K
YoY Change 77.12% -83.91%
Deferred Revenue
YoY Change
Short-Term Debt $302.3K $276.3K
YoY Change 9.39% -77.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.166M $1.535M
YoY Change -24.05% -58.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.166M $1.535M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.166M $1.535M
YoY Change -24.05% -58.75%
SHAREHOLDERS EQUITY
Retained Earnings -$166.5M
YoY Change
Common Stock $164.4M
YoY Change
Preferred Stock $1.385M
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$756.1K -$925.4K
YoY Change
Total Liabilities & Shareholders Equity $409.6K $609.5K
YoY Change -32.8% -65.28%

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$59.46K $119.6K
YoY Change -149.7% -123.2%
Depreciation, Depletion And Amortization $1.298K $1.300K
YoY Change -0.15% 71.05%
Cash From Operating Activities -$320.8K -$80.87K
YoY Change 296.74% -242.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 90.90K
YoY Change -309.69%
NET CHANGE
Cash From Operating Activities -$320.8K -80.87K
Cash From Investing Activities
Cash From Financing Activities 90.90K
Net Change In Cash -$320.8K $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$320.8K -$80.87K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000932021
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 GTLL Forgiveness Of Debt And Accrued Interest
ForgivenessOfDebtAndAccruedInterest
usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2022Q3 GTLL Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
usd
CY2022Q3 GTLL Forgiveness Of Debt And Accrued Interest
ForgivenessOfDebtAndAccruedInterest
usd
CY2022Q3 GTLL Loss On Issuance Of Notes Payable
LossOnIssuanceOfNotesPayable
usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2021Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q3 GTLL Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
usd
CY2022Q3 dei Entity File Number
EntityFileNumber
000-25668
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
GLOBAL TECHNOLOGIES, LTD
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0970492
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
510 1st Ave N.
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 901
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
St. Petersburg
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
372944 usd
CY2022Q3 GTLL Cancellation Of Common Stock To Be Issued
CancellationOfCommonStockToBeIssued
usd
CY2022Q3 us-gaap Investments
Investments
usd
CY2020Q3 us-gaap Investments
Investments
usd
CY2022Q3 us-gaap Goodwill
Goodwill
usd
CY2022Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
usd
CY2022Q2 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
usd
CY2022Q3 GTLL Forgiveness Of Debt Including Accrued Interest
ForgivenessOfDebtIncludingAccruedInterest
usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33701
CY2022Q3 dei City Area Code
CityAreaCode
(727)
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
482-1505
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q3 dei Trading Symbol
TradingSymbol
GTLL
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14488440097 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3648 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
324494 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5000 usd
CY2022Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
11932 usd
CY2022Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
7521 usd
CY2022Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
17380 usd
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
18380 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
37960 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
355395 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14717 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13419 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21646 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22944 usd
CY2022Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
350000 usd
CY2022Q2 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
350000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
371646 usd
CY2022Q3 us-gaap Assets
Assets
409606 usd
CY2022Q2 us-gaap Assets
Assets
728339 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
31438 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
15562 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
51953 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
47839 usd
CY2022Q3 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
300000 usd
CY2022Q2 GTLL Notes Payable Third Parties Current
NotesPayableThirdPartiesCurrent
387500 usd
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
2250 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
2250 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
49863 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
780071 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1272799 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1165712 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1676087 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1165712 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1676087 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14991000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
14991000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14488440097 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13785662319 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1448844 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1378566 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162913727 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
162732907 usd
CY2022Q3 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1385113 usd
CY2022Q2 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
1385113 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166503793 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166444337 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-756106 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-947748 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409606 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
728339 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
50000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
10000 usd
CY2022Q3 us-gaap Officers Compensation
OfficersCompensation
314467 usd
CY2021Q3 us-gaap Officers Compensation
OfficersCompensation
70087 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2021Q3 us-gaap Depreciation
Depreciation
1299 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
20900 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
20662 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2355 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16318 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
339020 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
108366 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-339020 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58366 usd
CY2021Q3 GTLL Forgiveness Of Debt And Accrued Interest
ForgivenessOfDebtAndAccruedInterest
433849 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
332630 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2083 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4411 usd
CY2021Q3 GTLL Loss On Issuance Of Convertible Notes
LossOnIssuanceOfConvertibleNotes
122046 usd
CY2022Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7614 usd
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
28983 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49863 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
106893 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
279564 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
178010 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59456 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
119644 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
119644 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14278428060 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
14537174609 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-947748 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
251098 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-756106 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1045063 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1045063 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
119644 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
119644 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-925419 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-925419 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-59456 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
119644 usd
CY2021Q3 GTLL Forgiveness Of Debt And Accrued Interest
ForgivenessOfDebtAndAccruedInterest
433849 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
332630 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2083 usd
CY2021Q3 GTLL Loss On Issuance Of Notes Payable
LossOnIssuanceOfNotesPayable
122046 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2021Q3 us-gaap Depreciation
Depreciation
1299 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
49863 usd
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
106893 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15000 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4411 usd
CY2022Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1000 usd
CY2021Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
20944 usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15876 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
138 usd
CY2022Q3 GTLL Increase Decrease In Accrued Interest Net
IncreaseDecreaseInAccruedInterestNet
7614 usd
CY2021Q3 GTLL Increase Decrease In Accrued Interest Net
IncreaseDecreaseInAccruedInterestNet
28983 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-320846 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80873 usd
CY2021Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6597 usd
CY2021Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
97500 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
90903 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-320846 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10030 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
324494 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56300 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3648 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66330 usd
CY2022Q3 GTLL Issuance Of Common Stock For Debt
IssuanceOfCommonStockForDebt
210833 usd
CY2021Q3 GTLL Cancellation Of Common Stock To Be Issued
CancellationOfCommonStockToBeIssued
68000 usd
CY2021Q4 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
25000 usd
CY2021Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
49000 usd
CY2022Q1 GTLL Agreement Description
AgreementDescription
the Company shall pay Donohoe an initial retainer in the amount of $17,500 and if successful a “success fee”
CY2022Q1 GTLL Success Fee Amount
SuccessFeeAmount
10000 usd
CY2022Q3 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_805_eus-gaap--BasisOfAccounting_z1f0IMaeWqyj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE B – <span id="xdx_825_z7SVZYRtLdvd">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and with Form 10-Q and Article 10 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2022 and the results of operations, changes in stockholders’ equity, and cash flows for the periods presented. The results of operations for the three months ended September 30, 2022 are not necessarily indicative of the operating results for the full fiscal year or any future period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 as filed with the Securities and Exchange Commission on October 13, 2022. The Company’s accounting policies are described in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended June 30, 2022, and updated, as necessary, in this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p>
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
50000 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3648 usd
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
0 usd
CY2022Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_z9QBerjbZLjk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zUP9nokFlKWb">Concentrations of Risks</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Accounts Receivable</span></i> –At September 30, 2022 and June 30, 2022, the Company had $<span id="xdx_901_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_do_c20220930_ztpsQRDKND46" title="Accounts receivables">5,000</span> and $<span id="xdx_906_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_do_c20220630_zec9ZEXFfMl7" title="Accounts receivables">5,000</span> in accounts receivable, respectively. For the three months ended September 30, 2022, one customer accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zGAXUcsJ37F5" title="Concentration risk percentage">100</span>% of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Revenues</span></i> – For the three months ended September 30, 2022, the Company generated $<span id="xdx_905_eus-gaap--Revenues_c20220701__20220930_z4hB0DhLq2J4">0 revenue. For the three months ended September 30, 2021, the Company generated $</span></span><span id="xdx_90A_eus-gaap--Revenues_c20210701__20210930_z9nEOxGaL3Dj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue from two customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Suppliers</span></i> – The Company relies on a limited number of suppliers and contract manufacturers. In particular, a single supplier is currently the sole manufacturer of the Company’s CBD products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Concentration of Loans Receivable, Other</span></i> –At September 30, 2022 and June 30, 2022, the Company had $<span id="xdx_90E_eus-gaap--OtherReceivablesNetCurrent_iI_do_c20220930__srt--MajorCustomersAxis__custom--OneBorrowerMember_zKgSvjQNvQZ5" title="Loans receivables other">17,380</span> and $<span id="xdx_904_eus-gaap--OtherReceivablesNetCurrent_iI_do_c20220630__srt--MajorCustomersAxis__custom--OneBorrowerMember_zlVreCLoUP0j" title="Loans receivables other">18,380</span> in loans receivable, other. At September 30, 2022 and June 30, 2022, one borrower accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_zwmVLCiBmUf7" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_zDVRdOg2aZGh" title="Concentration risk percentage">100</span></span>% of the Company’s total loans receivable, other. The one borrower is controlled by the Company’s sole officer and director.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><i><span style="text-decoration: underline">Concentration of Notes Receivable</span></i> <span style="background-color: white">– The Company had notes receivable of $</span><span id="xdx_902_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_do_c20220930__srt--MajorCustomersAxis__custom--OneBorrowerMember_zMS3gZbfMjud" title="Notes receivable">350,000</span><span style="background-color: white"> and $</span><span id="xdx_906_eus-gaap--NotesAndLoansReceivableNetNoncurrent_iI_do_c20220630__srt--MajorCustomersAxis__custom--OneBorrowerMember_z7OhfUldjIMc" title="Notes receivable">350,000</span><span style="background-color: white"> at September 30, 2022 and June 30, 2022, respectively. At September 30, 2022, one borrower accounted for </span><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--NotesReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneBorrowerMember_zBpEnWuRmB24" title="Concentration risk percentage">100</span><span style="background-color: white">% of the Company’s total notes receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5000 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
5000 usd
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16800000000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1548833791 shares
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zQLn7bAW0lwl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zYuh8OVxY8Me">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
546411 usd
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
70580 usd
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
36363 usd
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
653354 usd
CY2019Q4 us-gaap Goodwill
Goodwill
1346646 usd
CY2019Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
2000000 usd
CY2019Q4 us-gaap Goodwill
Goodwill
1346646 usd
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
-1346646 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
473323 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
873323 usd
CY2021Q3 us-gaap Depreciation
Depreciation
1299 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36363 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36363 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14717 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13419 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21646 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22944 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1298 usd
CY2022Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
350000 usd
CY2022Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
350000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
300000 usd
CY2022Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
387500 usd
CY2022 GTLL Forgiveness Of Debt Including Accrued Interest
ForgivenessOfDebtIncludingAccruedInterest
449293 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
780071 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1272799 usd
CY2022Q3 GTLL Preferred Stock Rank Description
PreferredStockRankDescription
All shares of the Series K Super Voting Preferred Stock shall rank (i) senior to the Corporation’s (A) Common Stock, par value $0.0001 per share (“Common Stock”), and any other class or series of capital stock of the Corporation hereafter created, except as otherwise provided in clauses (ii) and (iii) of this Section 4, (ii) pari passu with any class or series of capital stock of the Corporation hereafter created and specifically ranking, by its terms, on par with the Series K Super Voting Preferred-Stock and (iii) junior to any class or series of capital stock of the Corporation hereafter created specifically ranking, by its terms, senior to the Series K Preferred Stock, in each case as to distribution of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary.
CY2022Q3 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Class A Shares and the Class B Shares shall vote as a single class on all matters submitted to a vote of the stockholders, with each Class A Share being entitled to one (1) vote and each Class B Share being entitled to six (6) votes, except as otherwise provided by law.
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166503793 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-320846 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
gtll-20220930_cal.xml Edgar Link unprocessable
0001493152-22-033104-index-headers.html Edgar Link pending
0001493152-22-033104-index.html Edgar Link pending
0001493152-22-033104.txt Edgar Link pending
0001493152-22-033104-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gtll-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
gtll-20220930_def.xml Edgar Link unprocessable
gtll-20220930_lab.xml Edgar Link unprocessable
gtll-20220930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending